European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
Condition(s) studied
Investigational drug(s) / intervention(s)
Deep Brain Stimulation: surgical procedure
Study summary
Obsessive-Compulsive Disorder (OCD) is among the most disabling psychiatric disorders as more than 40% of patients are resistant to the standard pharmacological and psychotherapy approaches and about 10% show severe disability and require institutionalization. These resistant patients may benefit from new surgical therapeutic approaches such as Deep Brain Stimulation (DBS) using high frequency stimulation of specific cerebral regions to modulate neural networks. Although promising, these results need nevertheless to be replicated and confirmed within a larger cohort of patients and considering a different main objective, instead of clinical improvement only. Indeed, despite a positive treatment response, adaptive functioning and quality of life may continue to be negatively impacted in OCD. Thus beyond symptom reduction, health-related quality of life (QoL) represents a more important objective of a treatment, as it includes both the individual's functional status and the individual's subjective perception of the impact of the illness on the patient's life. STN DBS induces significant clinical improvement, which may not be proportional to the QoL gain. Consequently, QoL appears to be a better outcome to target in the coming studies than clinical improvement alone. THe investigators thus propose a prospective study assessing the QoL changes of resistant OCD patients under STN DBS+BMT versus Best Medical Treatment (BMT) at 12 months, in order to assess the DBS induced gain in QoL in BMT-managed patients versus BMT alone.
Eligibility
Primary outcome measure(s)
- Assessment of the impact of DBS+BMT versus BMT alone on a measure of Quality of life in resistant OCD patients at 1-year follow-up — 1 year
QOL assessment : scores at SF36
Trial sites (8)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU Henri Mondor | Créteil | France | Completed |
| University Hospital of Grenoble Michallon | Grenoble | France | Recruiting |
| Chu Nice - Hopital Pasteur | Nice | France | Recruiting |
| APHP La Pitié Salpêtrière | Paris | France | Recruiting |
| Ghu Sainte Anne | Paris | France | Recruiting |
| Universitätsklinikum Köln (AöR) | Cologne | Germany | Recruiting |
| Djurfeldt | Stockholm | Sweden | Recruiting |
| Hôpitaux Universitaires de Genève | Geneva | Switzerland | Recruiting |
More University Hospital, Grenoble trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT02844049 on ClinicalTrials.gov ↗ ← All trials in France